Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2006; 12(3): 403-407
Published online Jan 21, 2006. doi: 10.3748/wjg.v12.i3.403
Table 1 Serum amylase in all experimental groups (U/L, mean±SD)
Group Serum amylase
3 h(n=6)6 h(n=6)
Sham499.4 ± 86.3503.8 ± 91.2
AHNP10 444.5 ± 1 863.2b13 316.4 ± 1 374.1b
GdCl3 pretreatment9 107.1 ± 569.9b12 420.4 ± 1 779.2b
Table 2 Influence of GdCl3 on hepatic functions of experimental animals (U/L, mean±SD)
GroupnSerum ASTSerum ALT
Sham 3 h674.2 ± 13.631.6 ± 9.3
Sham 6 h671.3 ± 15.032.7 ± 11.3
GdCl3 control682.5 ± 14.628.9 ± 8.7
Table 3 Serum TNF-α and IL-1 in all experimental groups (mean±SD)
GroupnTNF-α (pg/mL)IL-1 (μg/L)
3 h
Sham632.0 ± 8.60.29 ± 0.08
AHNP6113.9 ± 18.50.81 ± 0.11
GdCl3 pretreatment671.1 ± 14.3b0.49 ± 0.12b
6 h
Sham631.9 ± 8.20.28 ± 0.07
AHNP6126.3 ± 12.60.91 ± 0.12
GdCl3 pretreatment678.0 ± 17.2b0.53 ± 0.13b
Table 4 Lung tissue MPO level in all groups (mU/mg prot, mean±SD)
Group MPO
3 h(n = 6)6 h(n = 6)
Sham0.51 ± 0.130.50 ± 0.17
AHNP1.59 ± 0.261.79 ± 0.23
GdCl3 pretreatment0.94 ± 0.15b1.02 ± 0.19b
Table 5 Histopathologic scores of lung tissue in all groups (mean±SD)
GroupLung histopathologic scores
3 h(n = 6)6 h(n = 6)
Sham0.17±0.040.17±0.04
AHNP2.50±0.55b2.67±0.52b
GdCl3 pretreatment1.87±0.41a2.00±0.38a